ClinVar Miner

Submissions for variant NM_000180.4(GUCY2D):c.3098C>T (p.Ser1033Leu)

gnomAD frequency: 0.00106  dbSNP: rs146149224
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen RCV005053934 SCV005687741 likely benign GUCY2D-related recessive retinopathy 2025-01-30 reviewed by expert panel curation The NM_000180.4(GUCY2D):c.3098C>T (p.Ser1033Leu) variant is predicted to replace the serine at position p.1033 with leucine. This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.003423, with 284 alleles / 75032 total alleles in the African/African American population, which is higher than the ClinGen LCA / eoRD VCEP BS1 threshold of >0.0016 (BS1). The computational predictor REVEL gives a score of 0.203, which is below the ClinGen LCA / eoRD VCEP threshold of ≤0.290 and predicts a non-damaging effect on RetGC-1 protein function. In addition, the splicing impact predictor SpliceAI gives a delta score of 0.00, which is below the ClinGen LCA/eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Likely Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BS1, BP4. (VCEP specifications version 1.0.0; date of approval 01/22/2025).
Eurofins Ntd Llc (ga) RCV000585411 SCV000226559 uncertain significance not provided 2018-06-19 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000585411 SCV000692893 uncertain significance not provided 2017-08-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001083338 SCV001100631 likely benign Cone-rod dystrophy 6; Leber congenital amaurosis 1 2024-12-24 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003982924 SCV004799872 likely benign GUCY2D-related disorder 2019-05-06 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.